Immune-mediated inflammatory diseases and nutrition: results from an online survey on patients' practices and perceptions.
Dietary behavior
Immune-mediated inflammatory diseases
Online patient community
Patient’s perception
Journal
BMC nutrition
ISSN: 2055-0928
Titre abrégé: BMC Nutr
Pays: England
ID NLM: 101672434
Informations de publication
Date de publication:
16 Jul 2021
16 Jul 2021
Historique:
received:
29
12
2020
accepted:
26
05
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
The central role of microbiota and the contribution of diet in immune-mediated inflammatory diseases (IMID) are increasingly examined. However, patients' perspectives on nutrition and its impact on their disease has not received a lot of attention. We aimed to directly collect information from patients with IMID about their dietary behaviors and their perceptions of the influence of nutrition on their disease. Adult patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, ulcerative colitis or psoriasis registered in an online patient community were invited to participate in the study and complete an online self-administered questionnaire. We assessed patients' dietary knowledge and choices by collecting information on the diet regimens they were following or recommended and their perceptions of the diet and its consequences on their disease. Fifty patients per target disease were included with a mean age of 48.1 years (95%CI 46.7-49.6). Other sociodemographic and clinical characteristics varied across the diseases. Since diagnosis, 44% of the patients changed their eating habits, mainly patients with inflammatory bowel disease with 69% of these making the change on their own initiative. Patients who did not change their diet habits reported not having received nutritional advice from their healthcare professionals (HCP) in 69% of the cases. The perceived impact of nutrition on their symptoms was mixed (overall 74% of the patients reported positive consequences and 60% negative ones) and varied across the diseases. Patients with psoriasis only experienced positive consequences from changing their diet, such as reduction of stress and improved mental health, while patients with Crohn's disease reported more negative effects such as increased fatigue and disturbed sleep. Patients with rheumatic diseases and ulcerative colitis reported weight loss and better physical fitness, but also increased fatigue. Even if differences exist across diseases, the importance of nutrition and its potential positive role in symptom management is acknowledged by the majority of the patients. However, there is a need and a demand from patients to receive more dietary advice. Developing therapeutic education tools on nutrition for people with IMID and involving patients' organizations would provide useful information and encourage communication between HCP and patients.
Sections du résumé
BACKGROUND
BACKGROUND
The central role of microbiota and the contribution of diet in immune-mediated inflammatory diseases (IMID) are increasingly examined. However, patients' perspectives on nutrition and its impact on their disease has not received a lot of attention. We aimed to directly collect information from patients with IMID about their dietary behaviors and their perceptions of the influence of nutrition on their disease.
METHODS
METHODS
Adult patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, ulcerative colitis or psoriasis registered in an online patient community were invited to participate in the study and complete an online self-administered questionnaire. We assessed patients' dietary knowledge and choices by collecting information on the diet regimens they were following or recommended and their perceptions of the diet and its consequences on their disease.
RESULTS
RESULTS
Fifty patients per target disease were included with a mean age of 48.1 years (95%CI 46.7-49.6). Other sociodemographic and clinical characteristics varied across the diseases. Since diagnosis, 44% of the patients changed their eating habits, mainly patients with inflammatory bowel disease with 69% of these making the change on their own initiative. Patients who did not change their diet habits reported not having received nutritional advice from their healthcare professionals (HCP) in 69% of the cases. The perceived impact of nutrition on their symptoms was mixed (overall 74% of the patients reported positive consequences and 60% negative ones) and varied across the diseases. Patients with psoriasis only experienced positive consequences from changing their diet, such as reduction of stress and improved mental health, while patients with Crohn's disease reported more negative effects such as increased fatigue and disturbed sleep. Patients with rheumatic diseases and ulcerative colitis reported weight loss and better physical fitness, but also increased fatigue.
CONCLUSIONS
CONCLUSIONS
Even if differences exist across diseases, the importance of nutrition and its potential positive role in symptom management is acknowledged by the majority of the patients. However, there is a need and a demand from patients to receive more dietary advice. Developing therapeutic education tools on nutrition for people with IMID and involving patients' organizations would provide useful information and encourage communication between HCP and patients.
Identifiants
pubmed: 34266484
doi: 10.1186/s40795-021-00446-y
pii: 10.1186/s40795-021-00446-y
pmc: PMC8283994
doi:
Types de publication
Journal Article
Langues
eng
Pagination
38Informations de copyright
© 2021. The Author(s).
Références
Am J Gastroenterol. 2011 Apr;106(4):563-73
pubmed: 21468064
Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
J Intern Med. 2015 Oct;278(4):369-95
pubmed: 26212387
Soc Sci Med. 2007 Mar;64(6):1297-310
pubmed: 17174016
Arthritis Res Ther. 2010;12(6):147
pubmed: 21092150
Nurs Forum. 2009 Jan-Mar;44(1):25-36
pubmed: 19187051
BMC Med. 2013 Mar 18;11:73
pubmed: 23497011
Nutrients. 2019 Nov 04;11(11):
pubmed: 31689999
Nutrients. 2020 May 18;12(5):
pubmed: 32443535
Environ Health Perspect. 2011 Jun;119(6):A249-53
pubmed: 21628113
Health Expect. 2014 Aug;17(4):545-54
pubmed: 22512818
Front Immunol. 2016 Apr 26;7:139
pubmed: 27199979
Lupus. 2014 May;23(6):518-26
pubmed: 24763536
Genome Med. 2016 Apr 21;8(1):43
pubmed: 27102666
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1433-1436
pubmed: 28196925
J Crohns Colitis. 2014 Oct;8(10):1179-207
pubmed: 24909831
Immunity. 2014 Jun 19;40(6):833-42
pubmed: 24950203
BMJ. 2008 Sep 11;337:a1344
pubmed: 18786971
Therapie. 2017 Feb;72(1):135-143
pubmed: 28139283
Manag Care. 2016 Jul;25(7):28-32
pubmed: 28121529
Sci Rep. 2016 Aug 02;6:30594
pubmed: 27481047
Mult Scler. 2005 Feb;11(1):24-32
pubmed: 15732263
Nutrients. 2018 Apr 26;10(5):
pubmed: 29701656
Mol Cell Endocrinol. 2017 Nov 5;455:4-12
pubmed: 28137612
Front Med (Lausanne). 2018 May 15;5:141
pubmed: 29868593
Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):411-25
pubmed: 21651358
World J Gastroenterol. 2016 Feb 21;22(7):2179-94
pubmed: 26900283
PLoS One. 2017 Dec 19;12(12):e0189840
pubmed: 29261752
Reumatologia. 2018;56(1):45-54
pubmed: 29686443
Gastroenterology. 2015 May;148(6):1087-106
pubmed: 25597840
J Am Acad Dermatol. 2009 Sep;61(3):405-10
pubmed: 19700012
Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G327-G339
pubmed: 28039159
mSystems. 2017 Sep 5;2(5):
pubmed: 28904997
Qual Life Res. 2014 Feb;23(1):195-203
pubmed: 23852096